Eva Santamaria

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Journal: Molecular therapy. Oncology

Published: January 20, 2026

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Journal: Cell reports. Medicine

Published: July 27, 2025

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

Journal: Oncoimmunology

Published: March 03, 2025

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Journal: Blood

Published: October 30, 2024

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis.

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis.

Journal: Journal of translational medicine

Published: September 14, 2024

Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma.

Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma.

Journal: Biomolecules

Published: April 29, 2024

New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study.

New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 16, 2023

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Journal: Nature metabolism

Published: October 25, 2022

Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice.

Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice.

Journal: Molecular metabolism

Published: May 22, 2022

FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma.

FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 27, 2022

A new animal model of atrophy-hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits.

A new animal model of atrophy-hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits.

Journal: Scientific reports

Published: May 20, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026